Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10597913 | 0.83 | CYP3A4 (0.37) | CYP3A4TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL305858 | 0.81 | CYP3A4 (0.54) | CYP3A4TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL9680266 | 0.81 | CYP3A4 (0.54) | CYP3A4TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL305859 | 0.81 | CYP3A4 (0.54) | CYP3A4TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL9680269 | 0.81 | CYP3A4 (0.54) | CYP3A4TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL10458459 | 0.81 | CYP3A4 (0.54) | CYP3A4TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL3384405 | 0.81 | CYP3A4 (0.60) | CYP3A4TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL10458458 | 0.81 | CYP3A4 (0.54) | CYP3A4TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL15430 | 0.80 | CYP3A4 (0.70) | CYP3A4TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL20621314 | 0.79 | ALDH1A1 (0.42) | CYP3A4TSHRALDH1A1TDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 516 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240332628-A1 | Silicon-Based Energy Storage Devices With Electrolyte Containing Cyanate Based Compounds | ENEVATE CORP (US) | 2024-10-03 | — | — | US | claimed |
| CN-113684469-B | Organic protective coating for electronic device and preparation method thereof | 宁波摩华科技有限公司 | 2023-08-22 | — | — | CN | claimed |
| CN-113684469-A | Organic protective coating for electronic device and preparation method thereof | 宁波摩华科技有限公司 | 2021-11-23 | — | — | CN | claimed |
| US-20210249689-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS | ENEVATE CORPORATION | 2021-08-12 | — | — | US | claimed |
| WO-2021158366-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS | ENEVATE CORPORATION (US) | 2021-08-12 | — | — | WO | claimed |
| CN-111933589-B | Packaging structure and preparation process thereof | 立讯电子科技（昆山）有限公司 | 2021-02-09 | — | — | CN | claimed |
| CN-111933589-A | Packaging structure and preparation process thereof | 立讯电子科技（昆山）有限公司 | 2020-11-13 | — | — | CN | claimed |
| CN-108047368-B | Preparation method and application of isocyanate polymer | 宁波大学 | 2020-10-30 | — | — | CN | claimed |
| US-9493670-B2 | Coatings that provide hydrophilic surface | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2016-11-15 | — | — | US | claimed |
| US-20160075906-A1 | COATINGS THAT PROVIDE HYDROPHILIC SURFACE | CRESTLINE DIRECT FINANCE, L.P. | 2016-03-17 | — | — | US | claimed |
| US-5484850-A | Copolymers crosslinkable by a free radical method | BASF AKTIENGESELLSCHAFT (DE) | 1996-01-16 | — | — | US | claimed |
| US-5424366-A | Graft polymerization of an addition polymer with a monomer prepared by an aminoalkyl phenothiazine and an unsaturated compound containing a reactive group to form an additive for engine lubricates | TEXACO INC. (US) | 1995-06-13 | — | — | US | claimed |
| EP-0595921-A1 | PREPARATION OF NONLINEAR OPTICAL ELEMENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-05-11 | — | — | EP | claimed |
| EP-0583417-A1 | CROSSLINKED POLED POLYMERS FOR NONLINEAR OPTIC APPLICATIONS AND METHOD OF MAKING THEM. | DU PONT (US) | 1994-02-23 | — | — | EP | claimed |
| US-5266651-A | Crosslinked poled polymers for nonlinear optic applications and method of making them | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-11-30 | — | — | US | claimed |
| US-5213934-A | Core of colorant and binder grafted to polymeric shell | XEROX CORPORATION (US) | 1993-05-25 | — | — | US | claimed |
| WO-1993002384-A1 | PREPARATION OF NONLINEAR OPTICAL ELEMENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-02-04 | — | — | WO | claimed |
| WO-1992019654-A1 | CROSSLINKED POLED POLYMERS FOR NONLINEAR OPTIC APPLICATIONS AND METHOD OF MAKING THEM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-11-12 | — | — | WO | claimed |
| US-5021177-A | Lubricating oil containing graft polymer with ethylene backbone | TEXACO INC. (US) | 1991-06-04 | — | — | US | claimed |
| US-4764304-A | Hydrocarbon compositions containing polyolefin graft polymers | TEXACO INC. (US) | 1988-08-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240332628-A1 | Silicon-Based Energy Storage Devices With Electrolyte Containing Cyanate Based Compounds | SIRT3, SLC6A12, HCN2 | CYP3A4 4039/4885TSHR 4711/4885ALDH1A1 1987/4885 |
| US-20210249689-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE CONTAINING CYANATE BASED COMPOUNDS | SIRT3, SLC6A12, HCN2 | CYP3A4 4039/4885TSHR 4711/4885ALDH1A1 1987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.